Cargando…
Intrathecal baclofen therapy versus conventional medical management for severe poststroke spasticity: results from a multicentre, randomised, controlled, open-label trial (SISTERS)
BACKGROUND: Intrathecal baclofen (ITB) is a treatment option for patients with severe poststroke spasticity (PSS) who have not reached their therapy goal with other interventions. METHODS: ’Spasticity In Stroke–Randomised Study' (SISTERS) was a randomised, controlled, open-label, multicentre ph...
Autores principales: | Creamer, Michael, Cloud, Geoffrey, Kossmehl, Peter, Yochelson, Michael, Francisco, Gerard E, Ward, Anthony B, Wissel, Jörg, Zampolini, Mauro, Abouihia, Abdallah, Berthuy, Nathalie, Calabrese, Alessandra, Loven, Meghann, Saltuari, Leopold |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031277/ https://www.ncbi.nlm.nih.gov/pubmed/29326296 http://dx.doi.org/10.1136/jnnp-2017-317021 |
Ejemplares similares
-
Effect of Intrathecal Baclofen on Pain and Quality of Life in Poststroke Spasticity: A Randomized Trial (SISTERS)
por: Creamer, Michael, et al.
Publicado: (2018) -
Intrathecal Baclofen in Hereditary Spastic Paraparesis
por: Pucks-Faes, Elke, et al.
Publicado: (2019) -
On the recovery of disorders of consciousness under intrathecal baclofen administration for severe spasticity—An observational study
por: Halbmayer, Lucas‐Michael, et al.
Publicado: (2022) -
EUROPEAN EXPERT CONSENSUS ON IMPROVING PATIENT SELECTION FOR THE MANAGEMENT OF DISABLING SPASTICITY WITH INTRATHECAL BACLOFEN AND/OR BOTULINUM TOXIN TYPE A
por: BIERING-SØRENSEN, Bo, et al.
Publicado: (2021) -
Intrathecal baclofen in paroxysmal sympathetic hyperactivity: Impact on oral treatment
por: Pucks‐Faes, Elke, et al.
Publicado: (2018)